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ABC of obesity
Childhood obesity
John J Reilly, David Wilson
Obesity, an excessive body fat content with increased risk of
morbidity, has become increasingly common in children and
adolescents. Confusion exists, however, over basic questions
such as whether paediatric obesity matters, how to diagnose it,
and whether it should be treated (and if so, how best to do this).
Doctors in many fields need a better understanding of these
issues.
Diagnosis
Subjective assessment methods are inaccurate, so diagnosis
must be objective. A substantial and consistent body of high
quality evidence has shown that body mass index (BMI; weight
in kilograms divided by height in metres squared) can be used
to diagnose obesity effectively.
BMI is lower in childhood and adolescence than in
adulthood and differs between boys and girls. Clinically, no
diagnostic alternative exists, therefore, to considering BMI in an
age and sex specific manner, either by plotting it on a BMI
chart or by referring to tables of BMI for age and sex.
In the United Kingdom, BMI for age charts represent the
distribution of BMI in children in 1990. Diagnosing obesity as a
high BMI centile (such as the 98th centile or above on the UK
charts) identifies the fattest children in the population with high
specificity (low false positive rate). High specificity provides
confidence that a child diagnosed as obese in this way actually is
excessively fat, and not simply muscular. In addition, strong
evidence shows that children with a high BMI centile are at
high risk of comorbid conditions, so the diagnosis is clinically
meaningful.
For comparisons of obesity prevalence between nations,
“international” definitions of overweight and obesity based on
BMI for age are available. These are designed to provide
definitions that are conceptually equivalent to adult BMI values
of 25 and 30 respectively.
Despite high specificity for excess fatness, a high BMI for
age has only modest sensitivity in children and adolescents
(moderate false negative rate). Modest sensitivity is a problem
for public health applications such as surveillance of obesity, as
estimates of prevalence of obesity based on BMI tend to be
conservative.
Future research may provide useful diagnostic alternatives
to BMI, and the use of waist circumference in the paediatric age
range is promising, though not yet sufficiently evidence based.
Prevalence
In the UK the epidemic of paediatric obesity began in the late
1980s. Prevalence has continued to increase rapidly, and obesity
is now the most common disorder of childhood and
adolescence. The health survey for England 2004 showed that
14% of 2-11 year olds and 25% of 11-15 year olds were obese
(BMI ≥ 95th centile).
In the United States, prevalence of childhood obesity is
highest in some ethnic minority groups; preliminary evidence
suggests that this might also be the case in Europe, although
further research is necessary and will require oversampling of
children and adolescents from ethnic minority groups.
This article summarises recent evidence based clinical
guidelines and systematic reviews and proposes
strategies for managing paediatric obesity
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Simplified diagram of some body mass index curves seen on UK BMI charts
for boys (that for girls is similar). The charts are available from Harlow Health
via the Child Growth Foundation (www.childgrowthfoundation.org)
Evidence based definitions of paediatric obesity
For research and epidemiological purposes
x Overweight should be defined as BMI ≥ 85th centile for sex and age
x Obesity should be defined as BMI ≥ 95th centile for sex and age
For clinical purposes in UK
x Overweight should be defined as BMI ≥ 91st centile if using the UK
BMI charts
x Obesity should be defined as BMI ≥ 98th centile if using the UK
BMI charts
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Development of epidemic of obesity in English children during
the 1990s. Adapted from Reilly et al (Lancet 1999;354:1874-5)
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Excess obesity is a particularly important clinical issue in
certain ethnic groups, such as South Asians. South Asians are
more sensitive to the adverse effects of excess weight gain and
account for most childhood cases of type 2 diabetes in the UK.
Consequences of childhood obesity
A systematic review and critical appraisal recently concluded
that paediatric obesity was a major health burden not only in
childhood and adolescence but also later on, in adulthood.
Short term
Many obese patients seeking medical care experience teasing
and bullying and will have low self esteem or a poor quality of
life. Paediatric obesity is also associated with many other
comorbid conditions. Evidence on some important
comorbidities (such as liver disease) and on the adverse
economic effects of paediatric obesity has only emerged
recently, and the list of adverse consequences will lengthen in
the near future.
From a public health viewpoint the most serious
consequence of obesity in childhood may be its damaging long
term effects on individuals’ cardiovascular health.
Cardiovascular risk factors are common, particularly in obese
adolescents, and tend to “cluster” (aggregate) in obese
individuals. For example, in a non-clinical sample of adolescents
in the United States, 29% of those who were obese had the
metabolic syndrome compared with 0.1% of those who were
not overweight.
Long term
Evidence linking childhood obesity to adult disease and
premature mortality is difficult to obtain and is currently
limited. However, systematic review and critical appraisal is
supportive of the hypothesis that paediatric obesity has adverse
effects on health in adulthood.
Obesity tends to persist, particularly from adolescence into
adulthood. Children are least likely to “grow out of” obesity
when it is more severe and when they have at least one obese
parent, and both of these features are much more common now
than in the past. These days, at least 60% of obese children and
70-80% of obese adolescents are likely to become obese adults.
Prevention
The evidence on interventions for prevention has recently been
reviewed systematically and critically appraised. Few
randomised controlled trials have been conducted. Most trials
were found to be methodologically weak and short term, and
most of the interventions tested were unlikely to be
generalisable.
Few trials found benefits linked to the intervention being
tested. One notable exception, however, is the “Planet Health”
intervention in US schoolchildren, which was of high
methodological quality, reasonably long term, generalisable, and
successful (at least in girls). The success of this particular
intervention was attributed largely to reductions in television
viewing.
Further research on preventive interventions is needed
urgently. A helpful guide to preventive interventions was
proposed by Whitaker. One barrier to such interventions is the
common perception among parents, teachers, and health
professionals that the interventions may cause harm (for
example, by promoting eating disorders). Such adverse effects
are extremely unlikely.
Obesity is more common in older children and
adolescents than in younger children; in the developed
world it is slightly more common in children from less
affluent families, for reasons that are unclear
Consequences of paediatric obesity
Short term (for the child or adolescent)
x Psychological ill health
x Cardiovascular risk factors
x Asthma
x Chronic inflammation
x Diabetes (type 1 and 2)
x Orthopaedic abnormalities
x Liver disease
Long term (for the adult who was obese as a child or adolescent)
x Persistence of obesity
x Adverse socioeconomic outcomes, particularly in women
x Cardiovascular risk factors, diabetes, cancers, depression, arthritis
x Premature mortality
Obesity in adolescence,
particularly in girls, is
associated with impaired
adult socioeconomic
outcomes such as poorer
educational results and
lower income
“Planet Health” trial*
Intervention
x Was conducted over two school years; 1295 participants aged 11
years at baseline
x Aimed to reduce television viewing, increase lifestyle physical
activity, reduce fat intake, and increase fruit and vegetable intake
x Intervention was tested rigorously in a high quality randomised
trial
x Intervention is probably generalisable
x Assessment of economic impact was carried out
Outcomes
x School based changes were sustainable and cost effective
x Benefits to intervention were found in girls (reduced risk of
becoming obese, remission of existing obesity)
x Benefits were attributed to reductions in television viewing
*Trial of model programme for school based obesity prevention (further details
from Gortmaker et al. Arch Pediatr Adolesc Med 1999;151:409-15)
Guide to prevention interventions*
Interventions should:
x Do no harm
x Lead to benefiting child health or development in other ways
x Target behaviours that are causally related to the development of
obesity or to its maintenance
x Target behaviours that are modifiable
x Target behaviours that are measurable because (a) families would
otherwise find it difficult to make changes and (b) scientific
evaluation requires measurement
*Modified and expanded from Whitaker (Arch Pediatr Adolesc Med
2003;157:725-7)
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Treatment
Recent systematic reviews and critical appraisal exercises have
consistently concluded that the evidence on interventions to
treat paediatric obesity is extremely limited. Most of the
randomised controlled trials have been methodologically weak
and short term, and many have been unsuccessful. Most trials
tested interventions that are unlikely to be generalisable.
Systematic reviews have identified promising elements of
treatment from the literature.
No high quality evidence is currently available on the
medium to long term effects of surgical treatment, drug
treatment, or residential treatment. Longer term randomised
controlled trials of these forms of treatment are needed
urgently.
Audits of typical dietetic and paediatric treatment of obesity
in the US and in the UK usually report disappointing results. A
recently conducted five year audit of an obesity clinic at the
Royal Hospital for Sick Children in Edinburgh found that over
half of the patients who had been referred to the clinic did not
attend any of their appointments. Of the patients who attended
at least one appointment, only 22% maintained their weight
over six months.
Management
To know how to manage childhood obesity we need to know
who should be treated, who should be referred, and what the
treatment should aim for.
Systematic reviews and critical appraisals have concluded
that the evidence base (from reports from expert committees)
for providing answers to these questions is weak. Nevertheless,
these reports are likely to be extremely helpful in management.
Summary of reports from expert committees
Who should be treated?
As treatment of obesity requires long term adherence to
lifestyle changes, success is unlikely if patients and/or their
family do not perceive obesity as a problem or if they are poorly
motivated to make lifestyle changes.
The disappointing results of treatment from past audits
partly reflect a lack of understanding among families that
paediatric obesity matters. Treatment should be reserved for
families who perceive obesity as a problem and who show
motivation to make and sustain lifestyle changes.
Who should be referred?
Referral from primary to secondary care would be justified for
two reasons: to investigate possible underlying pathological
causes of the patient’s obesity; and to investigate or manage a
possible comorbid condition such as type 2 diabetes.
In the vast majority of patients obesity is caused by lifestyle;
pathological causes are extremely rare. An underlying
pathological cause should be suspected, however, if obesity is
particularly severe in young children (where it may reflect an
underlying genetic cause such as a single gene defect) or if it
coexists with short stature (which may indicate a syndromic
cause such as the Prader-Willi syndrome or some other
endocrine cause).
If referral to secondary care reveals no comorbidities
requiring urgent treatment and no underlying pathological
causes of obesity, patients could be discharged to primary care
for treatment. However, in many parts of the UK treatment of
childhood obesity is either limited or not offered at all in
primary or secondary care.
Useful tips when treating paediatric obesity
x Treat as “intensively” as possible—more frequent and longer
appointments are beneficial
x Treat the whole family, not just the child
x Treat only motivated families
x Aim for dietary changes, perhaps using a “traffic light”
approach—that is, greatly restrict foods high in energy (“red”);
restrict foods with moderate energy content (“amber”) to meal
times only; eat freely foods that are low in energy (“green”) and
substitute them for red foods
The possibility of causing harm is also perceived by
parents, teachers, and health professionals as a barrier
to treatment, but the evidence suggests that this is
unlikely. In fact, with some treatment interventions the
psychosocial wellbeing of those being treated actually
improved
Reports on management from expert committees
x Management of obesity in children and young people. Guideline No 69
from SIGN (Scottish Intercollegiate Guidelines Network), 2003.
www.sign.ac.uk/guidelines/fulltext/69/index.html (accessed 18
Oct)
x Summerbell CD, Waters E, Edmunds LD, Kelly S, Brown T,
Campbell KJ. Interventions for preventing obesity in children.
Cochrane Database Syst Rev 2005;(3):CD001871.
x Summerbell CD, Ashton V, Campbell KJ, Edmunds L, Kelly S,
Waters E. Interventions for treating obesity in children. Cochrane
Database Syst Rev 2005;(3):CD001872.
x Canadian review of reviews 2004. www.irsc.gc.ca/e/23293.html.
x Clinical practice guidelines for the management of overweight and obesity
in children and adolescents. Australian review and evidence based
guidelines. www.obesityguidelines.gov.au.
x Gibson P, Edmunds L, Haslam DW, Poskitt E. An approach to
weight management in children and adolescents in primary care. J
Fam Health Care 2002;12:108-9.
x Barlow SE, Dietz WH. Obesity evaluation and treatment: expert
committee recommendations. Pediatrics 1998;102:E29.
Time spent playing computer games may need to be reduced if
an obese child is to achieve and maintain weight loss
Families can measure television viewing and related
sedentary behaviours; if they reduce their viewing, this
may result in them also reducing their food intake and
increasing their physical activity
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What should treatment aim for?
Weight maintenance over six to 12 months is considered to be a
success, particularly as continued excessive weight gain is
common in the absence of treatment. Weight maintenance is
also successful because, with growth, paediatric patients can to
some extent “grow into their weight.”
Weight loss is an unrealistic aim except if patients have
achieved prolonged weight maintenance or are severely obese
and so have to lose weight to enable management of
comorbidity such as type 2 diabetes or sleep apnoea. Progress
with management should be reviewed with the family using the
BMI centile chart periodically.
John J Reilly is professor of paediatric energy metabolism in the
University Division of Developmental Medicine, Yorkhill Hospitals,
Glasgow, and David Wilson is senior lecturer in the Division of Child
Life and Health, University of Edinburgh, Royal Hospital for Sick
Children, Edinburgh.
The ABC of Obesity is edited by Naveed Sattar
(nsattar@clinmed.gla.ac.uk), professor of metabolic medicine, and
Mike Lean, professor of nutrition, University of Glasgow. The series
will be published as a book by Blackwell Publishing in early 2007.
Aims of treatment
x To resolve comorbidity if it is present
x To achieve weight maintenance, not weight loss
x To ensure that families monitor their own diet, activity, television
viewing, and computer use
x To introduce dietary changes
x To reduce sedentary behaviour (particularly television viewing)—to
less than two hours a day
x To increase physical activity through lifestyle changes such as
walking to and from school
Further reading
x Neovius M, Linne Y, Barkeling B, Rossner S. Discrepancies between
classification systems of childhood obesity. Obes Rev
2004;52:105-14.
x Rudolf MCJ. The obese child. Arch Dis Child Educ Pract
2004;89:ep57-62. (http://adc.bmjjournals.com/).
x Viner R, Nicholls D. Managing obesity in secondary care. Arch Dis
Child 2005;90:385-90.
x Stewart L, Houghton J, Hughes AR, Pearson D, Reilly JJ. Dietetic
management of pediatric overweight: development and description
of an evidence-based, behavioral, approach. J Am Diet Assoc
2005;105:1810-5.
x Kopelman PG, Caterson ID, Dietz WH, eds. Clinical obesity in adults
and children. 2nd ed. Malden, MA: Blackwell, 2005.The ABC series—published by Blackwell Publishing
From January 2007, ABC articles will no longer be
serialised in the BMJ, but Blackwell Publishing is
delighted to continue the successful ABC book series.
With over 40 titles, this series provides a dependable
reference on a range of topics across the major
specialties. For further details, please visit
www.bmjbooks.com
The photographs of adolescent girls and of a child playing a computer
game are published with permission from Bubbles and Gusto/SPL
respectively.
Competing interests: For series editors’ competing interests, see the first
article in this series.
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A memorable patient
The Swan Lady
It is 1946. A young woman is dying of breast cancer in a side
street in Streatham. This is before the days of chemotherapy, and
her radiotherapy has badly burnt and scarred her. The family
doctor tells her distraught husband that there is no more he can
do for her. “If they had not cut into the cancer, she might have
survived.” A small girl overhears these words and never forgets
them. The doctor leaves, and shortly the young woman dies, with
little dignity as, in those days, morphine is used sparingly for fear
of addiction.
Sixty years later, an elderly woman consults her oncologist. For
seven years she has lived with breast cancer but has refused
treatment. Her disease is now very advanced. She is beginning to
lose her concentration, and, realising that her memory is
becoming faulty, she decides she had better seek orthodox
medical advice for the last time. I examine her and find a huge,
fixed, offensive cancer of her left breast. Her liver is grossly
enlarged. She is cachectic, and there are skin deposits on her back
and abdomen. She dresses.
Back in the consulting room, I am surprised to find her a
sophisticated and attractive lady, quite invisible as a patient behind
her clothes. She has a gentle, cultured voice. I ask her what she used
to do for a living. After being widowed early and childless, she had
given educational lectures all around the country.
“What were they on?” I ask her.
“Many things, but mainly on swans.”
“What sort of swan?” I go on, fancying myself as a bit of an
ornithologist.
“Mute swans,” she answers.
“And why swans?”
“Because swans are such elegant and beautiful creatures. They
are greatly harmed by fishermen, and much maligned. They mate
for life, take care of their young, and will fight and die for each
other.”
There is nothing I can say. This perceptive, cultured, and
sensitive woman has allowed her breast cancer to progress
untreated for the past seven years, refusing all conventional
treatment, because of what she overheard as a small child 60
years ago. Those words, spoken in ignorance but never doubted
by her, were her death sentence, as lethal as any bullet.
What can we learn from the Swan Lady? To take care what
we tell our patients and to remember the power our words
can have. Sometimes our greatest strength, like the swan, is in
silence.
Dick Ashford consultant clinical oncologist,Mount Vernon Hospital,
Chipperfield (dickashford@doctors.org.uk)
We welcome articles up to 600 words on topics such as
A memorable patient, A paper that changed my practice,My most
unfortunate mistake,or any other piece conveying instruction,
pathos, or humour. Please submit the article on http://
submit.bmj.com Permission is needed from the patient or a
relative if an identifiable patient is referred to. We also welcome
contributions for “Endpieces,” consisting of quotations of up to
80 words (but most are considerably shorter) from any source,
ancient or modern, which have appealed to the reader.
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